One Huntington Quadrangle, Suite 4N10, Melville, NY 11747

Ph: (631) 465.0606 | Email: info@jmbrassillgroup.com

Benefits Buzz May 2024 | New York Benefits Partners

Prescription Drug Report Is Due by June 1, 2024 Group health plans must annually submit detailed information on prescription drug and health care spending to the federal government. This reporting is referred to as the “prescription drug data collection,” or the “RxDC report.” The next RxDC report is due by Saturday, June 1, 2024, covering … Continued

Benefits Buzz April 2024 | New York Benefits Agency

DOL Releases ERISA Enforcement Results for 2023 The U.S. Department of Labor (DOL) has released the results of its Employee Benefits Security Administration’s (EBSA) enforcement actions during fiscal year (FY) 2023. The DOL has broad authority to investigate or audit an employee benefit plan’s compliance with ERISA. EBSA handles audits of employee benefit plans for … Continued

Benefits Buzz February 2024 | New York Benefits Agency

ACA Reporting Deadlines Are Approaching Employers subject to Affordable Care Act (ACA) reporting under Internal Revenue Code Sections 6055 or 6056 should prepare to comply with upcoming reporting deadlines. For the 2023 calendar year, covered employers must: Furnish statements to individuals by March 1, 2024 (an alternative method of furnishing statements to covered individuals is … Continued

Benefits Breakdown January 2024 | NY Benefits Team

4 Key Trends Driving Employer Health Care Costs in 2024 Amid ongoing inflation pressures, employees and employers alike can expect their health care costs to increase in 2024. Global professional services firm Aon reported that health care costs for employers will grow by 8.5% in 2024 (to more than $15,000 per employee), nearly double 2023’s … Continued

Benefits Buzz December 2023 | New York Benefits Agency

IRS Announces Employee Benefit Plan Limits for 2024 Many employee benefits are subject to annual dollar limits that are updated for inflation before the beginning of each calendar year. Most of these annual dollar limits will increase in 2024. Note that some benefit limits are not adjusted for inflation, such as the contribution limit for … Continued

Benefits Buzz – November 2023 | NY Benefits Team

Final Forms and Instructions for 2023 ACA Reporting Released The IRS has released final 2023 forms and instructions for reporting under Internal Revenue Code Sections 6055 and 6056: 2023 Forms 1094-B and 1095-B (and instructions) will be used by providers of minimum essential coverage, including self-insured plan sponsors that are not applicable large employers (ALEs), … Continued

Benefits Breakdown September 2023 | New York Employee Benefits Firm

2024 Open Enrollment: The Power of Early Preparation With the 2024 open enrollment season fast approaching, employers have an opportunity to develop attractive benefits offerings and proactively communicate with employees to win them over. Early preparation can help show employees they’re valued, convince top performers to stay in their current positions and attract new talent. … Continued

Benefits Buzz August 2023 | New York Benefits Group

Draft Forms for 2023 ACA Reporting Released The IRS has released draft 2023 forms for reporting under Internal Revenue Code Sections 6055 and 6056. Draft instructions for these forms have not yet been released. 2023 draft Forms 1094-B and 1095-B are drafts of the forms used by providers of minimum essential coverage, including self-insured plan … Continued

Benefits Breakdown – August 2023 | New York Benefits Partners

Strategies for Identifying and Resolving Gaps in Benefits Offerings Identifying gaps in benefits offerings can be complex, as it requires a careful assessment of employee preferences, trends and organizational resources. However, this task is vital; benefits offerings can lead to increased employee engagement and satisfaction. Consider the following strategies for identifying and addressing these gaps: … Continued

Benefits Breakdown July 2023 | New York Benefits Agency

Managing Costs Associated With Cell and Gene Therapy Cell and gene therapy (CGT) is a treatment that modifies a patient’s genetic code to treat or cure specific diseases. These treatments have the potential to enhance patient care and outcomes, but they come at a very high cost. While there’s an urgency to bring CGT to … Continued